MedPath

Quantitative Determination of Nadifloxacin in Follicles of Acne Patients Treated by Topical Nadifloxacin With or Without Adapalene and Benzoyl Peroxide

Not Applicable
Conditions
Acne
Registration Number
JPRN-UMIN000025358
Lead Sponsor
Toshitatsu Nogita
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

(1) The patient who had a following treatment within 4 weeks prior to the initiation of test drug treatment Facial chemical peering, Leaser therapy, or Phototherapy (2) The patient who had a following treatment within 2 weeks prior to the initiation of test drug treatment Use of Nadifloxacin on his/her face, Facial aesthetic treatment, Use of facial cleanser with scrub (3) The patient who would use or will not stop to use agent for skin (all of prescription medicine and OTC medicine) during the period of the study (4) Pregnant woman, might be pregnant woman, and/or Breastfeeding woman (5) The patient who is hypersensitivity to ingredients of test drug (6) The patient to whom physician recognize him/her will not be included in the study because of his/her history and complication of systemic diseases (7) The patient to who is participating other clinical research or study (8) The patient to whom physician judge as inappropriate for this clinical study due to safely issues

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
evel of Nadifloxacin in Follicles of Acne
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath